World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 95 906 825 81 76 554 30455
Medicine 96 9755 9155 946 902 562 30660

John D. Isaacs publications per year

The chart shows the history of publications by John D. Isaacs between 1956 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. John D. Isaacs published across 71 years, from 1956 to 2026, averaging 9.2 papers a year. Output peaked at 37 publications in 2019. 28 of the 654 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1956 to 2026. Vertical axis: number of publications, 0 to 37. Peak 37 publications in 2019. 1956: 1 publication 1957: 0 publications 1958: 0 publications 1959: 0 publications 1960: 0 publications 1961: 0 publications 1962: 0 publications 1963: 0 publications 1964: 0 publications 1965: 0 publications 1966: 0 publications 1967: 0 publications 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 3 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 1 publication 1986: 0 publications 1987: 1 publication 1988: 0 publications 1989: 0 publications 1990: 2 publications 1991: 0 publications 1992: 5 publications 1993: 6 publications 1994: 3 publications 1995: 8 publications 1996: 11 publications 1997: 10 publications 1998: 6 publications 1999: 5 publications 2000: 7 publications 2001: 10 publications 2002: 9 publications 2003: 9 publications 2004: 10 publications 2005: 20 publications 2006: 9 publications 2007: 8 publications 2008: 20 publications 2009: 20 publications 2010: 22 publications 2011: 19 publications 2012: 21 publications 2013: 32 publications 2014: 28 publications 2015: 36 publications 2016: 35 publications 2017: 36 publications 2018: 34 publications 2019: 37 publications 2020: 32 publications 2021: 31 publications 2022: 34 publications 2023: 25 publications 2024: 20 publications 2025: 27 publications 2026: 1 publication
1956 2026

654 publications in total across all disciplines

View publications per year as a table
John D. Isaacs: publications per year, 1956 to 2026
Year Publications
1956 1
1957 0
1958 0
1959 0
1960 0
1961 0
1962 0
1963 0
1964 0
1965 0
1966 0
1967 0
1968 0
1969 0
1970 0
1971 0
1972 0
1973 0
1974 0
1975 0
1976 0
1977 0
1978 0
1979 0
1980 0
1981 3
1982 0
1983 0
1984 0
1985 1
1986 0
1987 1
1988 0
1989 0
1990 2
1991 0
1992 5
1993 6
1994 3
1995 8
1996 11
1997 10
1998 6
1999 5
2000 7
2001 10
2002 9
2003 9
2004 10
2005 20
2006 9
2007 8
2008 20
2009 20
2010 22
2011 19
2012 21
2013 32
2014 28
2015 36
2016 35
2017 36
2018 34
2019 37
2020 32
2021 31
2022 34
2023 25
2024 20
2025 27
2026 1
Total 654
Download as CSV

John D. Isaacs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John D. Isaacs sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 552–561 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 554 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18 554
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

John D. Isaacs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Isaacs sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 94–95 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 95 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74 95
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 1974 - Member of the National Academy of Sciences

Overview

John D. Isaacs is a researcher affiliated with Newcastle University in the United Kingdom, with a focus on medicine and more specifically rheumatology. Their work covers various subfields including immunology, hematology, radiology, nuclear medicine and imaging, and genetics. Their research spans a variety of topics related to immune-mediated and inflammatory diseases.

Isaacs has contributed extensively to the study of rheumatoid arthritis and other autoimmune disorders. Some of the main topics of their work include:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Autoimmune and Inflammatory Disorders Research
  • Biosimilars and Bioanalytical Methods
  • Chronic Lymphocytic Leukemia Research
  • T-cell and B-cell Immunology

Isaacs' recent publications demonstrate research activity in clinical trials, treatment consensus, and biomarker analysis. Notable papers include:

  • "Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial" (2021, The Lancet)
  • "Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement" (2020, Annals of the Rheumatic Diseases)
  • "EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2" (2020, Annals of the Rheumatic Diseases)
  • "Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial" (2022, Nature Medicine)
  • "Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis" (2020, Nature Communications)

Their frequent co-authors include:

  • Arthur G. Pratt
  • Anne Barton
  • Ann W. Morgan
  • Kimme L Hyrich
  • Darren Plant

Isaacs has published in multiple journals with repeated contributions to:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • The Lancet Rheumatology
  • RMD Open
  • Arthritis & Rheumatology

Isaacs' research portfolio includes over 300 publications in medicine, with a significant focus on rheumatology as represented by 129 publications in that subfield. Other notable subfields include immunology and hematology.

Isaacs was recognized with the award of Member of the National Academy of Sciences in 1974.

Best Publications

  • The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography.

    Richard J. Wakefield;Wayne W. Gibbon;Philip G. Conaghan;Philip O'Connor

  • Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

    Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson

  • Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

    Wan Fai Ng;Phillip J. Duggan;Frederique Ponchel;Giuseppe Matarese

  • Cytokines in rheumatoid arthritis - shaping the immunological landscape.

    Iain B. McInnes;Christopher D. Buckley;John D. Isaacs

  • Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

    M.H. Buch;J.S. Smolen;N. Betteridge;F.C. Breedveld

  • Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions

    Frederique Ponchel;Carmel Toomes;Kieran Bransfield;Fong T Leong

  • Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

    Iain B. McInnes;Joachim Sieper;Juergen Braun;Paul Emery

  • Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial.

    Joel Kremer;Zhan-Guo Li;Stephen Hall;Roy Fleischmann

  • Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ Study

    Joanna Collerton;Carmen Martin-Ruiz;Karen Davies;Catharien M. Hilkens

  • Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis

    Philip G. Conaghan;Philip O'Connor;Dennis McGonagle;Paul Astin

  • Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

    Paul Emery;A. Deodhar;W. F. Rigby;J. D. Isaacs

  • Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells

    Muzlifah A. Haniffa;Xiao-Nong Wang;Udo Holtick;Michelle Rae

  • Integrated safety in tocilizumab clinical trials.

    Michael H Schiff;Joel M Kremer;Angelika Jahreis;Emma Vernon

  • Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers

    Philip M. Brown;Arthur G. Pratt;John D. Isaacs

  • Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?

    Kenneth F Baker;John D Isaacs;John D Isaacs

  • Humanised monoclonal antibody therapy for rheumatoid arthritis.

    J D Isaacs;R A Watts;B L Hazleman;G Hale

  • Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

    Mark G. Wing;Thibault Moreau;Judith Greenwood;Richard M. Smith

  • Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    Unknown

  • Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis

    G M Bell;A E Anderson;J Diboll;R Reece

  • Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood

    C. A. Lawson;A. K. Brown;V. Bejarano;S. H. Douglas

  • Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

    C Potter;K L Hyrich;A Tracey;M Lunt

  • Biologic therapies in rheumatology: lessons learned, future directions

    Vibeke Strand;Robert Kimberly;John D. Isaacs

Frequent Co-Authors

Ann W. Morgan
Ann W. Morgan University of Leeds
Anne Barton
Anne Barton University of Manchester
Paul Emery
Paul Emery University of Leeds
Anthony G. Wilson
Anthony G. Wilson University College Dublin
Kimme L. Hyrich
Kimme L. Hyrich University of Manchester
Catharien M. U. Hilkens
Catharien M. U. Hilkens Newcastle University
Herman Waldmann
Herman Waldmann University of Oxford
Iain B. McInnes
Iain B. McInnes University of Glasgow
Christopher D. Buckley
Christopher D. Buckley University of Oxford
Andrew Filer
Andrew Filer University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can open up diverse career opportunities. Those looking for practical entry points into healthcare may consider LPN programs. Identifying the best easiest lpn programs to get into can help beginners start their careers efficiently while gaining essential patient care skills.

Advancing further, nurse practitioner degrees offer specialized clinical roles. If flexibility and program accessibility are priorities, knowing which nurse practitioner program is easiest can be valuable for choosing the right path without compromising quality education.

Mental health is a growing area within healthcare where Immunology and psychiatry intersect, particularly in research on neuroimmunology. For those interested in clinical practice, exploring the best online psychiatric mental health nurse practitioner programs provides options with strong clinical placement support.

Cost is often a critical factor in education decisions. Students can find affordable training by reviewing cheap psych np programs that offer quality coursework without excessive financial burdens.

Best Scientists Citing John D. Isaacs

Trending Scientists

Recently Published Articles